Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
Xiaodong Hou(First Affiliated Hospital of Henan University of Science and Technology), Wenwen Yue(Xinjiang University), Huixiong Xu(Fudan University), Shengbo Wu(Zhejiang Hospital), Liping Sun(Tongji University), Xuexia Shan(Tongji University), Yuting Shen(Northwest University), Qiuyan Li, Weichen Xu, Tingting Jiang(Wuhan University), Anqi Zhu(Tongji University), Dekuang Zhao(University of Miami), Bin Huang(North Sichuan Medical University), Shuo Liu(Tongji University), Shaoyue Li(Harbin Medical University)
Cited by 16
Related Papers
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
|Nature Communications|2019|586
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
|Oncogene|2014|267
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression
|Cancer Research|2016|186
Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
|Nature Communications|2022|173